Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by floatinketucky


V.TLT

RE:Study II Preliminary Results

floatinketucky wrote: As of November 29, 2021, Study II has enrolled and...

January 5, 2022

V.TLT

an additional three subjects out of the 11 without 2dose

Published Sept 1, 2021 On the Phase 2 study, Uddin said, “TLT reported an...

January 5, 2022

V.TLT

RE:RE:RE:RE:RE:RE:RE:RE:Bought 5000 more wts today @ .20

Cheap stock is drying up. Leg up is on the way.  Sellers are not...

January 5, 2022

V.TLT

Weather by Honest Mistake or intentional actions

Bogus information destroys creepdability.

January 5, 2022

V.TLT

RE:Tiny and unheard of. Regular purchases and short positions.

floatinketucky wrote: This company is tiny and unheard of to the broader...

January 5, 2022

V.TLT

RE:RE:TLTFF- In good standing to challenge Merck’s Keytruda.

Rodger was buying Dec 16th 2021.

January 4, 2022

V.TLT

RE:TLTFF- In good standing to challenge Merck’s Keytruda.

floatinketucky wrote:   SEPT 01 2021 Research Capital analyst Andr...

January 4, 2022

V.TLT

Me thinks... yes me does...

The market is reassing this company because of the recent CR rates published....

January 4, 2022

V.TLT

39-billion-dollar deal

AstraZeneca to Buy Alexion for $39 Billion in Rare-Disease Push https://www...

January 4, 2022

V.TLT

$TLTFF

jim crammer

January 4, 2022

V.TLT

OFF TOPIC

{^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com...

January 4, 2022

V.TLT

RE:The Analyst rated Theralase, then covid & under treatments.

floatinketucky wrote: TLT Stock Price, News and Analysis | Cantech Letter It...

January 4, 2022

V.TLT

Study II Preliminary Results

As of November 29, 2021, Study II has enrolled and provided the primary study...

January 3, 2022

V.TLT

Sustained Momentum on the call.

These three medical device stocks are buys September 10, 2021 TLTFF price...

January 3, 2022

V.TLT

The Analyst rated Theralase, then covid & under treatments.

TLT Stock Price, News and Analysis | Cantech Letter

January 3, 2022

V.TLT

Dr Arkady Mandel

"I am honored to return as the Interim CEO for the Company, as the...

January 3, 2022

V.TLT

RE:RE:Theralase Commences Development of Coronavirus Vaccine

In April 2021, Theralase® executed a Collaborative Research Agreement...

January 3, 2022

V.TLT

RE:Theralase Commences Development of Coronavirus Vaccine

Theralase® and PHAC are collaborating on the development and...

January 3, 2022

V.TLT

Theralase Commences Development of Coronavirus Vaccine

Theralase Commences Collaborative Research with National Microbiology...

January 3, 2022

V.TLT

Warren Buffett

"The stock market is a device for transferring money from the impatient...

January 3, 2022